The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1627
ISSUE1627
June 28, 2021
Estetrol/Drospirenone (Nextstellis) - A New Combination Oral Contraceptive
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Estetrol/Drospirenone (Nextstellis) - A New Combination Oral Contraceptive
June 28, 2021 (Issue: 1627)
The FDA has approved a combination oral
contraceptive containing the estrogen estetrol and the
progestin drospirenone (Nextstellis – Mithra/Mayne).
Estetrol is the first new estrogen to become available
in the US in 50 years. Drospirenone is...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.